01 1Cambrex Charles City, Inc.
01 1RPT193-1 Hemi-Tartrate
01 1U.S.A
NDC Package Code : 59116-7320
Start Marketing Date : 2019-10-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
29
PharmaCompass offers a list of RPT193 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right RPT193 manufacturer or RPT193 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred RPT193 manufacturer or RPT193 supplier.
PharmaCompass also assists you with knowing the RPT193 API Price utilized in the formulation of products. RPT193 API Price is not always fixed or binding as the RPT193 Price is obtained through a variety of data sources. The RPT193 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zelnecirnon manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zelnecirnon, including repackagers and relabelers. The FDA regulates Zelnecirnon manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zelnecirnon API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Zelnecirnon supplier is an individual or a company that provides Zelnecirnon active pharmaceutical ingredient (API) or Zelnecirnon finished formulations upon request. The Zelnecirnon suppliers may include Zelnecirnon API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zelnecirnon as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zelnecirnon API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zelnecirnon as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zelnecirnon and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zelnecirnon NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zelnecirnon suppliers with NDC on PharmaCompass.
We have 1 companies offering Zelnecirnon
Get in contact with the supplier of your choice:
